October 23, 2024Open Access

GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 Diabetes

Key Points

Key points are not available for this paper at this time.

Abstract

This pooled cross-sectional study explores prescribing rates for glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors among US patients with type 1 diabetes.

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Authors

Piaopiao Li

Stone Mountain Technologies (United States)

Zhiyan Li

Department of Science and Technology of Guangdong Province

Elizabeth W. Staton

University of Colorado Hospital

Journals

JAMA

Actions

Institutions

Emory University

University of Florida

Florida College

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

GLP-1 Receptor Agonist and SGLT2 Inhibitor Prescribing in People With Type 1 Diabetes

Key Points

Abstract

Citation Network

Connected Papers

Discussion

Authors

Journals

Actions

Institutions

References and Citations

Citation Network

Connected Papers

Discussion

Cite this study